These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 30009705)

  • 1. Synergistic Interplay of The Co-administration of Rifampin And Newly Developed Anti-TB Drug: Could It Be a Promising New Line of TB Therapy?
    Agoni C; Ramharack P; Soliman MES
    Comb Chem High Throughput Screen; 2018; 21(6):453-460. PubMed ID: 30009705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-inhibition as a strategic therapeutic approach to overcome rifampin resistance in tuberculosis therapy: atomistic insights.
    Agoni C; Ramharack P; Soliman ME
    Future Med Chem; 2018 Jul; 10(14):1665-1675. PubMed ID: 29957065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The EU approved antimalarial pyronaridine shows antitubercular activity and synergy with rifampicin, targeting RNA polymerase.
    Mori G; Orena BS; Franch C; Mitchenall LA; Godbole AA; Rodrigues L; Aguilar-Pérez C; Zemanová J; Huszár S; Forbak M; Lane TR; Sabbah M; Deboosere N; Frita R; Vandeputte A; Hoffmann E; Russo R; Connell N; Veilleux C; Jha RK; Kumar P; Freundlich JS; Brodin P; Aínsa JA; Nagaraja V; Maxwell A; Mikušová K; Pasca MR; Ekins S
    Tuberculosis (Edinb); 2018 Sep; 112():98-109. PubMed ID: 30205975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probing the Molecular Mechanism of Rifampin Resistance Caused by the Point Mutations S456L and D441V on Mycobacterium tuberculosis RNA Polymerase through Gaussian Accelerated Molecular Dynamics Simulation.
    Zhang Q; Tan S; Xiao T; Liu H; Shah SJA; Liu H
    Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32393493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural Basis of Mycobacterium tuberculosis Transcription and Transcription Inhibition.
    Lin W; Mandal S; Degen D; Liu Y; Ebright YW; Li S; Feng Y; Zhang Y; Mandal S; Jiang Y; Liu S; Gigliotti M; Talaue M; Connell N; Das K; Arnold E; Ebright RH
    Mol Cell; 2017 Apr; 66(2):169-179.e8. PubMed ID: 28392175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xpert(®) MTB/RIF detection of rifampin resistance and time to treatment initiation in Harare, Zimbabwe.
    Metcalfe JZ; Makumbirofa S; Makamure B; Sandy C; Bara W; Mason P; Hopewell PC
    Int J Tuberc Lung Dis; 2016 Jul; 20(7):882-9. PubMed ID: 27287639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular insight into multiple RpoB clinical mutants of Mycobacterium tuberculosis: An attempt to probe structural variations in rifampicin binding site underlying drug resistance.
    Srivastava G; Tripathi S; Kumar A; Sharma A
    Int J Biol Macromol; 2018 Dec; 120(Pt B):2200-2214. PubMed ID: 29981823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Previous treatment in predicting drug-resistant tuberculosis in an area bordering East London, UK.
    Melzer M; Gupta N; Petersen I; Cook S; Hall B
    Int J Infect Dis; 2010 Aug; 14(8):e717-22. PubMed ID: 20542460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal whole genome analysis of pre and post drug treatment Mycobacterium tuberculosis isolates reveals progressive steps to drug resistance.
    Datta G; Nieto LM; Davidson RM; Mehaffy C; Pederson C; Dobos KM; Strong M
    Tuberculosis (Edinb); 2016 May; 98():50-5. PubMed ID: 27156618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into RpoB clinical mutants in mediating rifampicin resistance in Mycobacterium tuberculosis.
    Nusrath Unissa A; Hassan S; Indira Kumari V; Revathy R; Hanna LE
    J Mol Graph Model; 2016 Jun; 67():20-32. PubMed ID: 27155814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired drug resistance in Mycobacterium tuberculosis isolates recovered from compliant patients with human immunodeficiency virus-associated tuberculosis.
    March F; Garriga X; Rodríguez P; Moreno C; Garrigó M; Coll P; Prats G
    Clin Infect Dis; 1997 Nov; 25(5):1044-7. PubMed ID: 9402354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for rifamycin resistance of bacterial RNA polymerase by the three most clinically important RpoB mutations found in Mycobacterium tuberculosis.
    Molodtsov V; Scharf NT; Stefan MA; Garcia GA; Murakami KS
    Mol Microbiol; 2017 Mar; 103(6):1034-1045. PubMed ID: 28009073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanistic Principles Behind Molecular Mechanism of Rifampicin Resistance in Mutant RNA Polymerase Beta Subunit of Mycobacterium tuberculosis.
    Singh A; Grover S; Sinha S; Das M; Somvanshi P; Grover A
    J Cell Biochem; 2017 Dec; 118(12):4594-4606. PubMed ID: 28485504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Tunisian Mycobacterium tuberculosis rifampin-resistant clinical isolates.
    Soudani A; Hadjfredj S; Zribi M; Masmoudi A; Messaoud T; Tiouri H; Fendri C
    J Clin Microbiol; 2007 Sep; 45(9):3095-7. PubMed ID: 17652484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining COLD-PCR and high-resolution melt analysis for rapid detection of low-level, rifampin-resistant mutations in Mycobacterium tuberculosis.
    Pang Y; Liu G; Wang Y; Zheng S; Zhao YL
    J Microbiol Methods; 2013 Apr; 93(1):32-6. PubMed ID: 23396215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RpoB gene mutations in rifampin-resistant Mycobacterium tuberculosis strains isolated in the Aegean region of Turkey.
    Avkan Oguz V; Eroglu C; Guneri S; Yapar N; Oztop A; Sanic A; Yuce A
    J Chemother; 2004 Oct; 16(5):442-5. PubMed ID: 15565909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of rpoB gene mutations in Mycobacterium tuberculosis].
    Yin LF; Lu XD; Meng SJ; Wang R
    Fen Zi Xi Bao Sheng Wu Xue Bao; 2006 Apr; 39(2):185-9. PubMed ID: 16944591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquisition of Rifampin Resistance in Pulmonary Tuberculosis.
    Kayigire XA; Friedrich SO; van der Merwe L; Diacon AH
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167550
    [No Abstract]   [Full Text] [Related]  

  • 19. Considering the role of four months of rifampin in the treatment of latent tuberculosis infection.
    Reichman LB; Lardizabal A; Hayden CH
    Am J Respir Crit Care Med; 2004 Oct; 170(8):832-5. PubMed ID: 15297274
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of Mutations Conferring Resistance to Rifampin in Mycobacterium tuberculosis Clinical Strains.
    Jagielski T; Bakuła Z; Brzostek A; Minias A; Stachowiak R; Kalita J; Napiórkowska A; Augustynowicz-Kopeć E; Żaczek A; Vasiliauskiene E; Bielecki J; Dziadek J
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30061294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.